Clinical Research – Clinical Warehouse Data Access
Clinical Data Access for Researchers
|The Clinical Data Warehouse.In late 2005, Boston Medical Center embarked on a new project to bring data at the hospital into a single relational data warehouse. This means that clinical researchers who have IRB/HIPAA approval can now, with the help of a database developer–
If your protocol has been approved by HIPAA and/or the IRB, then click here to access the data request form. Note that there is a charge for accessing the Data Warehouse for research purposes. To find out more about charges, click here. E-mail the Clinical Data Warehouse Research Manager, Linda Rosen with questions or a meeting request to discuss your particular data needs.
|SDK – Registration [start date: 10/03]
||Logician – Outpatient data [start date: 1999]
|SCM – Inpatient [start date: 2001]
||PICIS – Operating Room [start date: 3/04]
|IBEX – Emergency Dept [start date: 11/2004]
||Tumor Registry [start date: mid 1980’s]
|AICE – Infection Data [start date: 1/2000]
||EWS – Appointment Information
|EPIC [start date: 05/23/14 Inpatient and ED; 05/06/15 Outpatient]
||Other data sources will be added in the future.
Linda Rosen can assist researchers in the development of identified/de-identified datasets, recurring reports, web access to formatted queries and other datasets.The following links will help you get started on a new proposal:
|Office of Clinical Research|
|Is Your Research Covered By HIPAA’s Privacy Rule?|
|Contact Linda Rosen with questions.|
Data Security: Protected health information must be stored on a secure device–on a BUMC network drive, a password protected computer or on a peripheral device that is stored in a secured cabinet or office. Only the investigators approved by the IRB for the protocol may have access to the information. No protected health information shall be removed from BUMC. Identifiers should be destroyed when they are no longer required for the study. As soon as the investigator(s) have completed the study, the file/files should be destroyed.
The protected health information may not be re-used or disclosed to any other person or entity, except as required by law, for the authorized oversight of the research study, or for other research for which the use or disclosure of protected health information would be permitted by the Privacy Regulation 45CFR 164.512.